European Research Council

ADVANCED GRANTS

  • RECGLYCANMR: Breaking the limits in glycan recognition by NMR | Jesús Jiménez Barbero

    Ref: 788143 (2018-2023)
    Value: 2.499.980 €  

CONSOLIDATOR GRANTS

  • CancerADAPT: Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | Arkaitz Carracedo

    Ref: 819242 (2019-2024)
    Value: 1.999.882 € 

STARTING GRANTS

  • NextGen IO: Exploiting the hypoxia response in T cells for Next Generation Immuno-Oncology | Asís Palazón

    Ref: 804236 (2019-2024)
    Value: 1.993.575 €

  • ADJUV-ANT VACCINES: Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | Alberto Fernández Tejada

    Ref: 716878 (2017-2022)
    Value: 1.499.218,75 € 

FINISHED

  • Starting Grant: CANCERMETAB: Metabolic Requirements for prostate cancer cell fitness |Arkaitz Carracedo

    Ref: 336343 (2013-2019)
    Value: 1.498.686 €

  • Proof of Concept: MetaboMARKER: A metabolism bases prognostic biomarker for prostate cancer |Arkaitz Carracedo

    Ref: 754627 (2017-2018)
    Value: 150.000 €